View Future GrowthNevis Brands 過去の業績過去 基準チェック /06Nevis Brandsは31%の年平均成長率で業績を伸ばしているが、Personal Products業界はdecliningで0.01%毎年増加している。売上は成長しており、年平均69.1%の割合である。主要情報31.05%収益成長率50.07%EPS成長率Personal Products 業界の成長20.87%収益成長率69.05%株主資本利益率-28.39%ネット・マージン-16.22%前回の決算情報30 Nov 2025最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Jun 30Nevis Brands Inc., Annual General Meeting, Aug 27, 2025Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canadaお知らせ • Feb 21Nevis Brands Inc. announced that it expects to receive $0.1 million in fundingNevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board.お知らせ • Oct 27Nevis Brands Inc. announced that it expects to receive $0.225 million in fundingNevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance.お知らせ • Jul 04Nevis Brands Inc., Annual General Meeting, Aug 29, 2024Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canadaお知らせ • May 10Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington StateNevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan.お知らせ • Dec 19Nevis Brands Inc. Announces Product Extension in OhioNevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started.お知らせ • Jul 07Nevis Brands Inc. announced that it has received CAD 2 million in fundingOn July 6, 2023, Nevis Brands Inc. closed the transaction. The company issued 4,805,000 common shares at an issue price of CAD 0.10 per share for gross proceeds of CAD 480,500 in its second and final tranche closing. The company issued 2,402,500 share purchase warrants exercisable for one year at a price of CAD 0.20 per share. A finder’s fee of CAD 32,235 was paid and the finder was issued 230,250 warrants on the same terms as the private placement warrants. All shares have a hold period expiring November 7, 2023.お知らせ • Jun 17Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023. Location: Vancouver, BC Vancouver Canadaお知らせ • Jun 15+ 1 more updateNevis Brands Inc. Announces CEO ChangesNevis Brands Inc. announced that Patrick Gray resigned as the CEO of the Company and John Kueber was appointed as CEO.お知らせ • May 19Pascal Biosciences Inc.'s Shares Will Be De-Listed from the TSX.V At the Close of the Market on May 23, 2023Shareholders of Pascal Biosciences Inc. owning 56% of the issued shares of the company have approved the reorganization of the company, including delisting from the TSX Venture Exchange. Details of the reorganization were disclosed in prior releases dated Dec. 9, 2022, and Feb. 15, 2023. At the request of the Company, the Shares will be de-listed from the TSX.V at the close of the market on May 23, 2023. Immediately thereafter: (i) the Company's name will be changed to Nevis Brands Inc., (ii) the Shares will consolidate on the basis of one new share for five old shares, and (iii) the Company's board of directors and the CEO will change. A news release will be issued the next day providing details about the new directors and the CEO. The Company has received a conditional listing letter dated April 26, 2023 from the Canadian Securities Exchange (the "CSE"). That letter requires the Company's reorganization to complete on the day the Shares are listed on the CSE (the "Listing Date"). On the Listing Date, a private placement of $2,000,000 (the "Private Placement") and the acquisition of THC Essentials (the Acquisition") are required to close as well as issuing Shares for debt, which will complete the reorganization. Completion of the transactions disclosed in this press release are subject to a number of conditions, including closing the Private Placement and the Acquisition. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in further news releases or the CSE form 2AListing Statement, still to be finalized, any information released or received with respect to the transactions may not be accurate or complete and should not be relied upon. The Shares of the Company have been halted since the first week of December 2022.収支内訳Nevis Brands の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:NEVI.F 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費30 Nov 25201031 Aug 25201031 May 25201028 Feb 25201030 Nov 24201031 Aug 24201031 May 24101029 Feb 24101030 Nov 23101031 Aug 23001031 May 230-10028 Feb 23001030 Nov 22001031 Aug 220-11031 May 220-11028 Feb 220-11030 Nov 210-11031 Aug 210-10031 May 210-11028 Feb 210-11030 Nov 200-11031 Aug 200-22031 May 200-22029 Feb 200-32030 Nov 190-32131 Aug 190-53131 May 190-52128 Feb 190-42130 Nov 180-32131 Aug 180-21031 May 180-21028 Feb 180-21030 Nov 170-21031 Aug 170-21031 May 170-21028 Feb 170-21030 Nov 160-21031 Aug 160-21031 May 160-11029 Feb 160-11030 Nov 150-11031 Aug 150-100質の高い収益: NEVI.Fは現在利益が出ていません。利益率の向上: NEVI.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NEVI.Fは利益を出していないが、過去 5 年間で年間31%の割合で損失を削減してきた。成長の加速: NEVI.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: NEVI.Fは利益が出ていないため、過去 1 年間の収益成長をPersonal Products業界 ( -21.9% ) と比較することは困難です。株主資本利益率高いROE: NEVI.Fは現在利益が出ていないため、自己資本利益率 ( -28.39% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YHousehold 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 20:03終値2026/05/19 00:00収益2025/11/30年間収益2025/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nevis Brands Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 30Nevis Brands Inc., Annual General Meeting, Aug 27, 2025Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canada
お知らせ • Feb 21Nevis Brands Inc. announced that it expects to receive $0.1 million in fundingNevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board.
お知らせ • Oct 27Nevis Brands Inc. announced that it expects to receive $0.225 million in fundingNevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance.
お知らせ • Jul 04Nevis Brands Inc., Annual General Meeting, Aug 29, 2024Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canada
お知らせ • May 10Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington StateNevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan.
お知らせ • Dec 19Nevis Brands Inc. Announces Product Extension in OhioNevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started.
お知らせ • Jul 07Nevis Brands Inc. announced that it has received CAD 2 million in fundingOn July 6, 2023, Nevis Brands Inc. closed the transaction. The company issued 4,805,000 common shares at an issue price of CAD 0.10 per share for gross proceeds of CAD 480,500 in its second and final tranche closing. The company issued 2,402,500 share purchase warrants exercisable for one year at a price of CAD 0.20 per share. A finder’s fee of CAD 32,235 was paid and the finder was issued 230,250 warrants on the same terms as the private placement warrants. All shares have a hold period expiring November 7, 2023.
お知らせ • Jun 17Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023. Location: Vancouver, BC Vancouver Canada
お知らせ • Jun 15+ 1 more updateNevis Brands Inc. Announces CEO ChangesNevis Brands Inc. announced that Patrick Gray resigned as the CEO of the Company and John Kueber was appointed as CEO.
お知らせ • May 19Pascal Biosciences Inc.'s Shares Will Be De-Listed from the TSX.V At the Close of the Market on May 23, 2023Shareholders of Pascal Biosciences Inc. owning 56% of the issued shares of the company have approved the reorganization of the company, including delisting from the TSX Venture Exchange. Details of the reorganization were disclosed in prior releases dated Dec. 9, 2022, and Feb. 15, 2023. At the request of the Company, the Shares will be de-listed from the TSX.V at the close of the market on May 23, 2023. Immediately thereafter: (i) the Company's name will be changed to Nevis Brands Inc., (ii) the Shares will consolidate on the basis of one new share for five old shares, and (iii) the Company's board of directors and the CEO will change. A news release will be issued the next day providing details about the new directors and the CEO. The Company has received a conditional listing letter dated April 26, 2023 from the Canadian Securities Exchange (the "CSE"). That letter requires the Company's reorganization to complete on the day the Shares are listed on the CSE (the "Listing Date"). On the Listing Date, a private placement of $2,000,000 (the "Private Placement") and the acquisition of THC Essentials (the Acquisition") are required to close as well as issuing Shares for debt, which will complete the reorganization. Completion of the transactions disclosed in this press release are subject to a number of conditions, including closing the Private Placement and the Acquisition. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in further news releases or the CSE form 2AListing Statement, still to be finalized, any information released or received with respect to the transactions may not be accurate or complete and should not be relied upon. The Shares of the Company have been halted since the first week of December 2022.